Increase in mutant frequencies in mice expressing the BCR-ABL activated tyrosine kinase

Leukemia

Volumn 14, Issue 8, 2000, Pages 1401-1404

  Salloukh, H F ^a   Laneuville, P ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

BCR ABL; Genomic instability; Leukemia; Mutant frequency; Transgenic mice

Indexed keywords

BCR ABL PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ENZYME ACTIVATION; HEMATOLOGIC DISEASE; IN VIVO STUDY; KIDNEY; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; MOUSE; MUTAGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

EID: 0033891416     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401855     Document Type: Article

References (22)

1. Acute leukemia in bcr/abl transgenic mice
2. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: A novel transgenic model for human Ph1-positive leukemias
3. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
4. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
5. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway
6. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL
7. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway
8. Cytogenetics of chronic myelogenous leukemia
9. Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice
10. Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl
11. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
12. Expression of the chronic myelogenous leukemia- associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line
13. Transgenic systems for in vivo mutation analysis
14. Statistical approaches for analyzing mutational spectra: Some recommendations for categorical data
15. Restricted oncogenicity of BCR/ABL p190 in transgenic mice
16. Microsatellite instability: Marker of a mutator phenotype in cancer
17. Multiple mutations in human cancers
18. The molecular biology of chronic myeloid leukemia
19. Abl tyrosine protein kinase
20. Mutator phenotype of BCR-ABL transfected Ba/F3 cell lines at its association with enhanced expression of DNA polymerase β
21. Lack of DNA replication and repair factor RFC- P140 protein expression in CML
22. Database and software for the analysis of mutations at the Lacl gene in both transgenic rodents and bacteria